Dear lizmcdowell, In a pathology specimen there could be features indicating both in situ as well as invasive cancer. If there is any invasive component this is what treatment recommendations are based on. Although taken out of context, it sounds like they are talking about a 9cm specimen, but the cancerous component was greatest at 5cm. Lymphatic vasculature permeation is not referring to the lymph nodes. Like small blood vessels or capillaries that run through the breast, the lymphatic system also has a series of small vessels that run through the breast. Lymphatic vasculature permeation means that cancer cells were found invading these vessels, which can be a indicator of increased likelihood that cancer could spread, as evidenced by the positive lymph nodes.
All of the information on staging and the features of the tumor, are taken into account to make treatment recommendations. You have received appropriate adjuvant treatment in the hopes of decreasing the chance of recurrence of the breast cancer. People who are HER2 neu positive are thought to have a more aggressive cancer. Having said that, folks who are HER2 positive are also good candidates for Herceptin. In many cases, breast cancer can be controlled for a long time. It is possible that, at some point, you will experience a recurrence. Women can live a long time with breast cancer. If it does reoccur, many women live "well" with the disease.